(Q39666368)

13 September 2017

Further characterization of responses of infants and children to meningococcal A polysaccharide vaccine (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80171-7

26 April 2022

1 reference

bacterial polysaccharides

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A109592

26 April 2022

author name string

J. Wilkins

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A109592

26 April 2022

P. F. Wehrle

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A109592

26 April 2022

language of work or name

English

0 references

publication date

1 May 1979

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0022347679801717?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80171-7

https://api.elsevier.com/content/article/PII:S0022347679801717?httpAccept=text/plain

26 April 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80171-7

The Journal of Pediatrics

26 April 2022

published in

1 reference

13 September 2017

94

1 reference

13 September 2017

828-832

1 reference

13 September 2017

5

1 reference

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

Immunogenicity of the Group A and Group C Meningococcal Polysaccharides in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

Quantitative Determination of the Human Immune Response to Immunization with Meningococcal Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

Immunogenicity of group A and group C meningococcal polysaccharides in human infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

Response of children to Neisseria meningitidis polysaccharide vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

Effect of group-A meningococcal vaccine in army recruits in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

Vaccination against meningococcal group A disease in Finland 1974-75

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

Meningococcus group A vaccine in children three months to five years of age. Adverse reactions and immunogenicity related to endotoxin content and molecular weight of the polysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

Cutaneous Reactions and Antibody Response to Meningococcal Group C Polysaccharide Vaccines in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2879%2980171-7

A controlled field trial of a serogroup A meningococcal polysaccharide vaccine

7 January 2021

series ordinal

7

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(79)80171-7

26 November 2022

Identifiers

1 reference

13 September 2017

1 reference